121 related articles for article (PubMed ID: 26974375)
21. Biological study of a somatostatin mimetic based on the 1-deoxynojrimycin scaffold.
Zhao Y; Liu M; Chagnault V; Wang J; Zhang X; Murphy PV
Bioorg Med Chem Lett; 2011 Jan; 21(2):824-8. PubMed ID: 21194941
[TBL] [Abstract][Full Text] [Related]
22. Structure activity relationship exploration of 5-hydroxy-2-(3-phenylpropyl)chromones as a unique 5-HT
Kim M; Truss M; Pagare PP; Essandoh MA; Zhang Y; Williams DA
Bioorg Med Chem Lett; 2020 Nov; 30(21):127511. PubMed ID: 32853682
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of 2,3,6,8-tetrasubstituted chromone scaffolds.
Dahlén K; Wallén EA; Grøtli M; Luthman K
J Org Chem; 2006 Sep; 71(18):6863-71. PubMed ID: 16930039
[TBL] [Abstract][Full Text] [Related]
24. 3-Thio-1,2,4-triazoles, novel somatostatin sst2/sst5 agonists.
Contour-Galcéra MO; Sidhu A; Plas P; Roubert P
Bioorg Med Chem Lett; 2005 Aug; 15(15):3555-9. PubMed ID: 15982879
[TBL] [Abstract][Full Text] [Related]
25. A scaffold replacement approach towards new sirtuin 2 inhibitors.
Seifert T; Malo M; Kokkola T; Stéen EJL; Meinander K; Wallén EAA; Jarho EM; Luthman K
Bioorg Med Chem; 2020 Jan; 28(2):115231. PubMed ID: 31848116
[TBL] [Abstract][Full Text] [Related]
26. A bioactive somatostatin analog without a type II' beta-turn: synthesis and conformational analysis in solution.
Jiang S; Gazal S; Gelerman G; Ziv O; Karpov O; Litman P; Bracha M; Afargan M; Gilon C; Goodman M
J Pept Sci; 2001 Oct; 7(10):521-8. PubMed ID: 11695647
[TBL] [Abstract][Full Text] [Related]
27. Design and synthesis of novel chromenone derivatives as interleukin-5 inhibitors.
Venkateswararao E; Sharma VK; Lee KC; Roh E; Kim Y; Jung SH
Bioorg Med Chem; 2013 May; 21(9):2543-50. PubMed ID: 23523388
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis and antiviral activity of 2-(3-amino-4-piperazinylphenyl)chromone derivatives.
Kim MK; Yoon H; Barnard DL; Chong Y
Chem Pharm Bull (Tokyo); 2013; 61(4):486-8. PubMed ID: 23546009
[TBL] [Abstract][Full Text] [Related]
29. Drug design at peptide receptors: somatostatin receptor ligands.
Hannon JP; Nunn C; Stolz B; Bruns C; Weckbecker G; Lewis I; Troxler T; Hurth K; Hoyer D
J Mol Neurosci; 2002; 18(1-2):15-27. PubMed ID: 11931345
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of 2-alkyl-chroman-4-ones via cascade alkylation-dechlorination of 3-chlorochromones.
Li S; Zhang L; He Q; Zhang X; Yang C
Org Biomol Chem; 2021 Jun; 19(24):5348-5352. PubMed ID: 34042936
[TBL] [Abstract][Full Text] [Related]
31. Small molecule somatostatin receptor subtype-2 antagonists.
Hay BA; Cole BM; DiCapua FM; Kirk GW; Murray MC; Nardone RA; Pelletier DJ; Ricketts AP; Robertson AS; Siegel TW
Bioorg Med Chem Lett; 2001 Oct; 11(20):2731-4. PubMed ID: 11591512
[TBL] [Abstract][Full Text] [Related]
32. A tetradecapeptide somatostatin dicarba-analog: Synthesis, structural impact and biological activity.
Martín-Gago P; Ramón R; Aragón E; Fernández-Carneado J; Martin-Malpartida P; Verdaguer X; López-Ruiz P; Colás B; Cortes MA; Ponsati B; Macias MJ; Riera A
Bioorg Med Chem Lett; 2014 Jan; 24(1):103-7. PubMed ID: 24342240
[TBL] [Abstract][Full Text] [Related]
33. Tetrahydro-β-carboline-based spirocyclic lactam as type II' β-turn: application to the synthesis and biological evaluation of somatostatine mimetics.
Lesma G; Cecchi R; Cagnotto A; Gobbi M; Meneghetti F; Musolino M; Sacchetti A; Silvani A
J Org Chem; 2013 Mar; 78(6):2600-10. PubMed ID: 23409740
[TBL] [Abstract][Full Text] [Related]
34. Somatostatin receptor 1 selective analogues: 4. Three-dimensional consensus structure by NMR.
Grace CR; Durrer L; Koerber SC; Erchegyi J; Reubi JC; Rivier JE; Riek R
J Med Chem; 2005 Jan; 48(2):523-33. PubMed ID: 15658866
[TBL] [Abstract][Full Text] [Related]
35. Novel sst(4)-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling.
Erchegyi J; Waser B; Schaer JC; Cescato R; Brazeau JF; Rivier J; Reubi JC
J Med Chem; 2003 Dec; 46(26):5597-605. PubMed ID: 14667214
[TBL] [Abstract][Full Text] [Related]
36. Ultrasound-promoted greener synthesis of novel trifurcate 3-substituted-chroman-2,4-dione derivatives and their drug-likeness evaluation.
Liang C; Jiang H; Zhou Z; Lei D; Xue Y; Yao Q
Molecules; 2012 Nov; 17(12):14146-58. PubMed ID: 23192190
[TBL] [Abstract][Full Text] [Related]
37. Ligand design for somatostatin receptor isoforms 4 and 5.
Negi A; Zhou J; Sweeney S; Murphy PV
Eur J Med Chem; 2019 Feb; 163():148-159. PubMed ID: 30503939
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and Characterization of 5-Hydroxy-2-(2-phenylethyl)chromone (5-HPEC) and Its Analogues as Non-nitrogenous 5-HT2B Ligands.
Williams DA; Zaidi SA; Zhang Y
J Nat Prod; 2015 Aug; 78(8):1859-67. PubMed ID: 26270954
[TBL] [Abstract][Full Text] [Related]
39. Modulation of receptor and receptor subtype affinities using diastereomeric and enantiomeric monosaccharide scaffolds as a means to structural and biological diversity. A new route to ether synthesis.
Hirschmann R; Hynes J; Cichy-Knight MA; van Rijn RD; Sprengeler PA; Spoors PG; Shakespeare WC; Pietranico-Cole S; Barbosa J; Liu J; Yao W; Rohrer S; Smith AB
J Med Chem; 1998 Apr; 41(9):1382-91. PubMed ID: 9554871
[TBL] [Abstract][Full Text] [Related]
40. Discovery of thiochroman and chroman derivatives as pure antiestrogens and their structure-activity relationship.
Kanbe Y; Kim MH; Nishimoto M; Ohtake Y; Kato N; Tsunenari T; Taniguchi K; Ohizumi I; Kaiho S; Morikawa K; Jo JC; Lim HS; Kim HY
Bioorg Med Chem; 2006 Jul; 14(14):4803-19. PubMed ID: 16580210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
